Heads up:
Live Webinar, November 29: What the FDA’s Proposed Rule to Regulate Lab-Developed Tests Means for Hospitals and Health Systems
An ARUP expert will answer questions about a proposed FDA rule to regulate laboratory-developed tests (LDTs) as medical devices, which will potentially limit patient access to essential medical care.
Webinar Description (10 PT, 11 MT, 12 CT, 1 ET)
Join ARUP’s Jonathan Genzen, MD, PhD, chief medical officer and senior director of governmental affairs, on Wednesday, November 29, at 11 a.m. MST for a conversation about the FDA’s proposed rule to regulate LDTs as medical devices. He’ll address patient safety, test availability, and the impact on innovation. ARUP’s compliance officer,
Jonathan Carr, JD, will moderate a Q&A during the webinar.
